Guardian Pharmacy Services, Inc.
GRDN- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001802255
No open-market purchases or sales by Guardian Pharmacy Services, Inc. insiders were filed in the last 90 days; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +21 vs. previous quarter
- 190
- 13F valueReported value at the end of Q2 2026
- $1.24B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.45B
- No comparable prior period
- Net income, FY2025
- $49.2M
- No comparable prior period
- Free cash flow, FY2025
- $86.8M
- No comparable prior period
- Revenue, Q3 FY2026
- $371.1M
- −1.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.20M
- Shares sold short
- Change
- −178.9K
- −7.5% vs. previous
- Days to cover
- 6.64
- At average daily volume
Superinvestors holding GRDN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding GRDN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Guardian Pharmacy Services, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Morris David KSee Remarks | SSaleClass A Common Stock | −187.9K | $29.68 | −$5.58M | −42.5%254.5K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Pharmacy Investors, LLCOther: Member of 10% owner group | SSaleClass A Common Stock | −827.6K | $29.68 | −$24.6M | −44.4%1.04M after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Burke FredSee Remarks | SSaleClass A Common Stock | −671.4K | $29.68 | −$19.9M | −44.4%840.4K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Salentine Thomas J JrDirector, 10% Owner | SSaleClass A Common Stock | −3.57M | $29.68 | −$106.0M | −44.4%4.47M after | Duplicate filing |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Bindley Capital Partners I, LLC10% Owner | SSaleClass A Common Stock | −3.57M | $29.68 | −$106.0M | −44.4%4.47M after | Duplicate filing |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Ackerman JohnDirector | SSaleClass A Common Stock | −1.10M | $29.68 | −$32.7M | −76.2%345.1K after | 2 lots |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Bindley William EDirector, 10% Owner | SSaleClass A Common Stock | −3.57M | $29.68 | −$106.0M | −44.4%4.47M after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Forbes KendallSee Remarks | SSaleClass A Common Stock | −346.7K | $29.68 | −$10.3M | −43.3%453.3K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Cardinal Equity Fund, L.P.Other: Member of 10% owner group | SSaleClass A Common Stock | −275.7K | $29.68 | −$8.18M | −44.4%345.1K after | |
| Dec 5, 2025 (view filing) | Dec 3 | 2 days | Cosler Steven DDirector | PPurchaseClass A Common Stock | +3.37K | $29.61 | +$99.8K | +15.6%25.0K after |
Top 10 13F holders, Q2 2026
See all 190 holdersThe largest institutional positions in Guardian Pharmacy Services, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 3,241,612 | $135.7M | 0.01% | +882,255+37.4% | Added |
| Wellington Management Group LLP | 1,729,032 | $72.4M | 0.01% | −36,087−2.0% | Reduced |
| BlackRock, Inc. | 1,575,989 | $66.0M | 0.00% | −180,385−10.3% | Reduced |
| Vanguard Capital Management LLC | 1,379,750 | $57.8M | 0.00% | +154,207+12.6% | Added |
| Woodline Partners LP | 1,306,340 | $54.7M | 0.17% | +220.0% | Added |
| Valiant Capital Management, L.P. | 1,186,658 | $49.7M | 3.09% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 1,116,868 | $46.8M | 0.03% | +88,479+8.6% | Added |
| Boston Partners | 983,868 | $40.8M | 0.04% | −33,815−3.3% | Reduced |
| Franklin Resources Inc | 966,206 | $40.5M | 0.01% | +13,254+1.4% | Added |
| TimesSquare Capital Management, LLC | 951,637 | $39.8M | 0.59% | −125,837−11.7% | Reduced |
Holders of 5% or more of GRDN
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Guardian Pharmacy Services, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 13D/A | 26.40%16.7M shares | +5.10 ppfrom 21.30% | Feb 3, 20255 filings | Sep 28, 2026 | SEC |
| FMR LLC | 13G/A | 5.00%3.14M shares | −1.50 ppfrom 6.50% | May 6, 20262 filings | Nov 5, 2026 | SEC |